@article{140e9dfbf5674541b384ee90280cbc8d,
title = "Lessons from All-Rez Bfm 90: Therapy for childhoodleukemia based on timing and site of relapse",
keywords = "Acute lymphoblastic leukemia, ALL, ALL-REZ BFM 90, Bone marrow relapse, Children, Cytarabine, Etoposide, Event-free survival, Extramedullary relapse, Methotrexate .Radiotherapy, Pediatric, Polychemotherapy, Prognosis, Randomized controlled trial, Relapse, Risk factors, Stem cell transplantation, Testicular relapse",
author = "Rytting, {Michael E.}",
note = "Copyright: Copyright 2012 Elsevier B.V., All rights reserved.",
year = "2012",
month = mar,
doi = "10.1007/s11899-011-0112-z",
language = "English (US)",
volume = "7",
pages = "1--2",
journal = "Current hematologic malignancy reports",
issn = "1558-8211",
publisher = "Springer Science + Business Media",
number = "1",
}